Please use this identifier to cite or link to this item:http://hdl.handle.net/20.500.12105/13972
The Human Immunodeficiency Virus Continuum of Care in European Union Countries in 2013: Data and Challenges
Gourlay, Annabelle | Noori, Teymur | Pharris, Anastasia | Axelsson, Maria | Costagliola, Dominique | Cowan, Susan | Croxford, Sara | d'Arminio Monforte, Antonella | Amo, Julia del ISCIII | Delpech, Valerie | Díaz, Asunción ISCIII | Girardi, Enrico | Gunsenheimer-Bartmeyer, Barbara | Hernando, Victoria ISCIII | Jose, Sophie | Leierer, Gisela | Nikolopoulos, Georgios | Obel, Niels | Op de Coul, Eline | Paraskeva, Dimitra | Reiss, Peter | Sabin, Caroline | Sasse, André | Schmid, Daniela | Sonnerborg, Anders | Spina, Alexander | Suligoi, Barbara | Supervie, Virginie | Touloumi, Giota | Van Beckhoven, Dominique | van Sighem, Ard | Vourli, Georgia | Zangerle, Robert | Porter, Kholoud | European HIV Continuum of Care Working Group
Clin Infect Dis. 2017 Jun 15;64(12):1644-1656
Background: The Joint United Nations Programme on HIV/AIDS (UNAIDS) has set a "90-90-90" target to curb the human immunodeficiency virus (HIV) epidemic by 2020, but methods used to assess whether countries have reached this target are not standardized, hindering comparisons. Methods: Through a collaboration formed by the European Centre for Disease Prevention and Control (ECDC) with European HIV cohorts and surveillance agencies, we constructed a standardized, 4-stage continuum of HIV care for 11 European Union countries for 2013. Stages were defined as (1) number of people living with HIV in the country by end of 2013; (2) proportion of stage 1 ever diagnosed; (3) proportion of stage 2 that ever initiated ART; and (4) proportion of stage 3 who became virally suppressed (≤200 copies/mL). Case surveillance data were used primarily to derive stages 1 (using back-calculation models) and 2, and cohort data for stages 3 and 4. Results: In 2013, 674500 people in the 11 countries were estimated to be living with HIV, ranging from 5500 to 153400 in each country. Overall HIV prevalence was 0.22% (range, 0.09%-0.36%). Overall proportions of each previous stage were 84% diagnosed, 84% on ART, and 85% virally suppressed (60% of people living with HIV). Two countries achieved ≥90% for all stages, and more than half had reached ≥90% for at least 1 stage. Conclusions: European Union countries are nearing the 90-90-90 target. Reducing the proportion undiagnosed remains the greatest barrier to achieving this target, suggesting that further efforts are needed to improve HIV testing rates. Standardizing methods to derive comparable continuums of care remains a challenge.
Continuity of Patient Care | Disease Eradication | European Union | Anti-HIV Agents | Antiretroviral Therapy, Highly Active | Cohort Studies | Female | HIV | HIV Infections | Humans | Male | Mass Screening | Prevalence | United Nations | World Health Organization
Files in this item
- TheHumanImmunodeficiencyVirus_ ...
- Artículo principal